[ad_1] The United States Food and Drug Administration (FDA) has approved tafenoquine ( Krintafel ) to prevent the relapse of Malaria Plasmodium vivax in persons aged 16 and over. more who receive …
Read More »FDA Accepts Tafenoquine (Krintafel) to Prevent Malaria Relapse
